1. Opportunities and Challenges in the Management of Advanced STS

2. Program Goals

3. Sarcoma: The Scope of the Clinical Problem

4. Epidemiology of STS

5. Sarcomas: Biological Groups, Etiology, and Risk Factors

6. Diagnosis and Pathology of Sarcomas

7. Management of Sarcomas: Therapeutic Progress and Ongoing Clinical Needs

8. Doxorubicin vs Intensified Doxorubicin Plus Ifosfamide for Advanced STS: Phase 3

9. Doxorubicin vs Intensified Doxorubicin Plus Ifosfamide: Post-protocol Treatment

10. Pazopanib for Metastatic STS: Phase 3 PALETTE Trial

11. Subanalysis of Phase 2 and 3 Data of Long-term Responders on Pazopanib

12. HRQoL Reported in the PALETTE Study

13. Gemcitabine Plus Docetaxel vs Doxorubicin as First-line Therapy in Metastatic STS: Phase 3 GeDDis Trial

14. GeDDis Trial: Subgroup Analysis

15. Individualizing Therapy for Patients With Advanced STS

16. Abbreviations